» Articles » PMID: 37892260

Perception of Illness and Fear of Inhaled Corticosteroid Use Among Parents of Children with Asthma

Overview
Specialty Health Services
Date 2023 Oct 28
PMID 37892260
Authors
Affiliations
Soon will be listed here.
Abstract

The most prevalent children's chronic disease worldwide is asthma which has notable negative impacts on patients' and parent's quality of life. Daily inhaled corticosteroids (ICS) therapy is a preferred controller choice. This study was conducted on 148 parents of asthmatic children to establish parents' perception of illness and fear of inhaled corticosteroids using B-IPQ and TOPICOP questionnaires. Children were in the majority male (66.9%), older than five years (58.8%), with comorbidities, and family history of atopy. Parents were female, with a mean age of 38, employed, and with a history of some form of corticosteroid use. Most parents were not afraid of ICS usage (71.6%). Unemployed parents and parents who had no medical education had a statistically significantly higher fear of using ICS ( = 0.002, = 0.03). A child's illness affects the parents' lives and parents who are afraid of using ICS react more emotionally to the child's illness. Better understanding and less concerned about child's disease are parents of children with controlled asthma. The parents' perspective of children's asthma will affect the duration and dose of ICS treatment they will give to their children and directly influence the level of asthma control.

Citing Articles

Parents' Beliefs about Medicines and Their Influence on Inhaled Corticosteroid Adherence in Children with Asthma.

Duvnjak J, Ursic A, Matana A, Medvedec Mikic I Children (Basel). 2024; 11(2).

PMID: 38397279 PMC: 10887537. DOI: 10.3390/children11020167.

References
1.
Moret L, Anthoine E, Aubert-Wastiaux H, Le Rhun A, Leux C, Mazereeuw-Hautier J . TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One. 2013; 8(10):e76493. PMC: 3797828. DOI: 10.1371/journal.pone.0076493. View

2.
Adcock I, Ito K, Barnes P . Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc. 2005; 1(3):247-54. DOI: 10.1513/pats.200402-001MS. View

3.
Moore W, Meyers D, Wenzel S, Teague W, Li H, Li X . Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2009; 181(4):315-23. PMC: 2822971. DOI: 10.1164/rccm.200906-0896OC. View

4.
Axelsson I, Naumburg E, Prietsch S, Zhang L . Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth. Cochrane Database Syst Rev. 2019; 6:CD010126. PMC: 6564081. DOI: 10.1002/14651858.CD010126.pub2. View

5.
Hossny E, Rosario N, Lee B, Singh M, El-Ghoneimy D, Soh J . The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organ J. 2016; 9:26. PMC: 4982274. DOI: 10.1186/s40413-016-0117-0. View